Denali Therapeutics Inc. DNLI Purchases of intangible assets included in accrued expenses and other liabilities
Purchases of intangible assets included in accrued expenses and other liabilities at other companies
Other financials
Where this comes from
Reported directly by Denali Therapeutics Inc. in its filing.
Tagged under the XBRL concept us-gaap:NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1.
The official record: Denali Therapeutics Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Denali Therapeutics Inc.'s purchases of intangible assets included in accrued expenses and other liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Denali Therapeutics Inc.'s purchases of intangible assets included in accrued expenses and other liabilities?
- Denali Therapeutics Inc. (DNLI) reported purchases of intangible assets included in accrued expenses and other liabilities of $36M in Q1 2026.